[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369909-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369909-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","analysis-of-2023-world-health-organization-cancer-essential-medicines-list-and-concordance-with-resource-stratified-guidelines","Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines","","Background: The World Health Organization (WHO) Essential Medicines List (EML) and resource-stratified guidelines prioritize high-value cancer medicines. The study compares the 2023 WHO EML cancer medicines list with global cancer statistics, quantifies which EML therapies are supported by resource-stratified recommendations, and highlights gaps for consideration by the WHO EML Committee. Methods: Adult cancer EML medicines are matched against GLOBOCAN 2022 incidence and mortality data, and cross-referenced with NCCN and India NCG guidelines. Results: The 2023 EML includes 64 medicines across 219 indications, with leukemia and lymphoma dominating; unmet EML coverage corresponds to a substantial share of cancer deaths. Conclusions: Several effective medicines warrant evaluation for inclusion, showing broad alignment between EML and NCG India but discordance with NCCN.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/analysis-of-2023-world-health-organization-cancer-essential-medicines-list-and-concordance-with-resource-stratified-guidelines/369909/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/analysis-of-2023-world-health-organization-cancer-essential-medicines-list-and-concordance-with-resource-stratified-guidelines/369909.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the analysis?","Question",{"text":63,"@type":64},"To compare the 2023 WHO cancer Essential Medicines List with global cancer statistics, evaluate overlap with resource-stratified guidelines, and identify gaps worthy of review by the WHO EML Committee.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were EML cancer medicines evaluated in the methods?",{"text":68,"@type":64},"The study compared 2023 EML medicines for adult cancers with GLOBOCAN 2022 incidence and mortality data and cross-referenced the EML against two resource-stratified guidelines: NCCN and NCG (India).",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about guideline recommendations vs EML listings?",{"text":72,"@type":64},"For NCCN resource-stratified guideline indications included in the EML, recommendation rates differed between NCCN Basic and Core Guidelines, while for NCG indications the EML-aligned recommendation proportions were high for both Essential and Optimal guidelines.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369909,1790713186,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","JNCI: Journal of the National Cancer Institute, 2025, 117(10), 2010–2020  \n[https://doi.org/10.1093/jnci/djaf100](https://doi.org/10.1093/jnci/djaf100)  \nAdvance Access Publication Date: May 23, 2025  \nArticle  \nAnalysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines  \nBrooke E. Wilson , MSc, MBBS, MSc􀀃 ,1 ,2 ,3 , Kristin Wright , MD1, Manju Sengar, MD4, Richard Sullivan , PhD5,6, Sallie-Anne Pearson , PhD3, 7, Michael B. Barton , MD8, Bishal Gyawali , PhD1,2, Elisabeth De Vries , PhD9, Lorenzo Moja , PhD10, C. S. Pramesh , MS11, Christopher M. Booth , MD1, 2  \n1Department of Oncology, Queen’s University, Kingston, ON, Canada  \n2Division of Cancer Care and Epidemiology, Queen’s Cancer Research Institute, Kingston, ON, Canada 3School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sidney, NSW, Australia  \n4Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, National Cancer Grid, Mumbai, India 5Institute of Cancer Policy, King's College London, London, United Kingdom  \n6Department of Oncology, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom 7Menzies Centre for Health Policy, University of Sydney, Sidney, NSW, Australia  \n8Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia  \n9University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands 10Department of Health Product Policy and Standards, World Health Organization, Geneva, Switzerland  \n11Departments of Surgical Oncology and Administration, Tata Memorial Centre, Homi Bhabha National Institute, National Cancer Grid, Mumbai, India  \n􀀃 Corresponding author: Brooke Wilson, BSc, MBBS, MSc, FRACP, Department of Oncology, Queen’s University, Medical Oncologist, Cancer Centre of Southeastern Ontario at KHSC, 25 King St W, Kingston, ON K7L 5P9, Canada ([brooke.wilson@kingstonHSC.ca](brooke.wilson@kingstonHSC.ca)) .  \nAbstract  \nBackground: The World Health Organization (WHO) Essential Medicines List (EML) and resource-stratified guidelines both prioritize high-value medicines. We compared the 2023 EML cancer medicines list with global cancer statistics, examined the proportion of EML therapies recommended by resource-stratified guidelines, and identified gaps that merit evaluation by the WHO EML Committee.  \nMethods: We compared the 2023 EML medicines for adult cancers with cancer incidence and mortality data from GLOBOCAN 2022. We cross-referenced the EML with 2 resource-stratified guidelines (National Comprehensive Cancer Network [NCCN] and National Cancer Grid [NCG] of India) and evaluated preferred treatments in resource-stratified guidelines that were not recommended by the EML.  \nResults: The 2023 EML included 64 cancer medicines for 219 tumor-specific indications. The greatest number of medicines are listed for leukemia (37/219 [17%]) and lymphoma (33/219 [15%]) . Although some common cancers (eg, hepatocellular carcinoma) have no EML-listed medicines because of the low clinical benefit, we identified some cancers (eg, esophageal, gastric) with effective therapies that the EML Committee should evaluate for inclusion. Cancers with no listed medicines make up 34% of cancer deaths globally. Among EML indications with an NCCN resource-stratified guideline, 42%(35/84) and 73%(62/84) were recommended by the NCCN Basic and Core Guidelines, respectively. Among EML indications with an NCG resource-stratified guideline, 163 of 196 (83%) and 175 of 196 (89%) were recommended by the NCG Essential and Optimal guidelines, respectively.  \nConclusions: We identified some effective medicines that should be evaluated for inclusion in the WHO EML. Prioritization of cancer medicines was similar between the EML and NCG India but discordant between with NCCN resource-stratified guideline.  \nIntroduction  \nPrioritizing effective, safe, cost-effective, and affordable healthcare is a fundamental tenet of universal he","cbCaivH3UrfSJiTx","https://ap.wps.com/l/cbCaivH3UrfSJiTx","pdf",740165,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the main objective of the analysis?\",\"answer\":\"To compare the 2023 WHO cancer Essential Medicines List with global cancer statistics, evaluate overlap with resource-stratified guidelines, and identify gaps worthy of review by the WHO EML Committee.\"},{\"question\":\"How were EML cancer medicines evaluated in the methods?\",\"answer\":\"The study compared 2023 EML medicines for adult cancers with GLOBOCAN 2022 incidence and mortality data and cross-referenced the EML against two resource-stratified guidelines: NCCN and NCG (India).\"},{\"question\":\"What did the results show about guideline recommendations vs EML listings?\",\"answer\":\"For NCCN resource-stratified guideline indications included in the EML, recommendation rates differed between NCCN Basic and Core Guidelines, while for NCG indications the EML-aligned recommendation proportions were high for both Essential and Optimal guidelines.\"}]","Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource-stratified guidelines | PDF",1790185179,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11027114dadcc1aadf9748c0a657cf63.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96b530d0220b8526b75dfa5647288245.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73c36d578e080d53a571e536c838d9c0.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68e1c66fd6d372dcd249bd7dd84ed79e.webp",980,1287]